LJ-Bodhi
6 일 전
Quarterly Report is out with zero revenues last quarter. The company is changing up its products so it will be a complete guess how future sales will progress. One thing is for certain, it is a rinse and repeat stinky pinky stock when it comes to issuing new shares to fund operations. They reported the following new shares which nearly maxes out the AS (currently 1.25 billion shares):
Common Stock
The Company is authorized to issue 1,250,000,000 shares of $0.0001 par value common stock.
As of September 30, 2024 and December 31, 2023, there were 1,231,728,974 and 895,760,225 shares of the Company’s common stock issued and outstanding, respectively. In addition, as of September 30, 2024 and December 31, 2023, there were 10,000 shares of the Company’s common stock issuable.
Fiscal year 2024
During the nine months ended September 30, 2024, the Company issued 335,968,749 shares of common stock valued at $202,643 for conversion of debt.
The company clearly disclosed it will issue more shares throughout the year for operating cash, so expect an 8K filing down the road increasing the AS above 1.25 billion shares to make room for the rinse and repeat. All the new shares will continue to put downward pressure on the stock price. It will be interesting if they can generate any future volume on product press releases or social media rumors. Seems dead for now.
Nezitic
4 주 전
Let's be real, thanx to this RS a lot of us lost money, seems they overthinking, nobody will buy this a long period even after RS, they killed stock themselves, what a great management lol, nobody cares about their new line, flushed down with water...
JOHNNY-VEGAS
4 주 전
On Jan. 1, 2020, BioAdaptives® had 18,576,379 shares of common stock issued and outstanding. Then, stock was traded for funding to raise money to develop business plans, with the money spent on those plans. Unfortunately, the plans did not work, and the process was repeated until the quarterly report ending June 30, 2024, showed 1,231,728,974 common shares issued and outstanding without increasing revenue. That is roughly a 6,530% increase in shares in less than five years without success in the business plan. For BioAdaptives Inc. to reach just $1.00 per share, the market would have to view BioAdaptives as a $1,213,728,974 company. That number of shares guarantees the stock will remain in the sub-penny range.
Why is BioAdaptives® planning a reverse stock split?
When the new management took over, it was mutually agreed with past management that a new direction and a reverse split were needed. There was no sense in completing a reverse split until an achievable plan was in place that allowed the company to grow and have substance. Over the next few weeks and months, several outstanding products will be brought to market, and we expect BioAdaptives® to soon see increased revenue followed by profitability. The new CEO, James Keener, has a history of turning around underperforming companies. He stopped everything and changed direction to turn BioAdaptives® around. He moved because he is committed to making BioAdaptives® a genuine company with meaningful revenue, profits and share price.
The new product line has solid science behind it and high efficacy. We will soon be producing new offerings as we fill out our lines of human and animal products.
The marketing plan for our new products is much more comprehensive, with new distribution channels and standout packaging. This reverse is just one crucial step to turning around an underperforming company. I lost all my gains, but I am going to hold my position through this process. It’s a gamble I am willing to take the risk.
LJ-Bodhi
4 주 전
Why lash out just because facts are somehow disappointing? Here are some more facts to consider as part of what investors should be researching as due diligence. James Keener does have a track record.....and it's not very good. Remember how the BDPT press release touted him as a seasoned marketing and turnaround specialist:
https://www.streetinsider.com/Press+Releases/BioAdaptives%2C+Inc.+Appoints+James+Keener+as+New+CEO+to+Lead+Strategic+Growth+Initiatives/23254571.html
That Hawaii construction company is called Handy Andy. It is a noble business that helps veterans transition into meaningful employment. And there are reputable reports that the company was growing fast in 2019. However, public business filings in Hawaii paint the picture of what happened afterwards under the management of Mr. Keener:
https://hbe.ehawaii.gov/documents/business.html?fileNumber=164061C5
That company was registered as an LLC with Keener as the manager. The annual filings are basic forms and fees for an LLC. Keener could not manage to fulfill those basic tasks in 2020, 2021, and 2022, until the company was administratively terminated in 2023. Again, don't take my word for it, just read the public document I linked.
Thankfully, Handy Andy is going strong under the management of Andy C. who is a true veteran and there is no mention of Keener on the Yelp page:
https://www.yelp.com/biz/handy-andy-hawaii-honolulu
Meet the Manager
Business owner information
Andy C.
Manager
After ten years of serving the military, I felt it was time to start a new chapter in my life and join my family in Hawaii. When doing so, I experienced a variety of obstacles and hurdles to overcome, like something as simple as finding a job.
I had developed crucial skills and experience while serving the country, and while very useful in the day to day life of a civilian, they didn't exactly build up a proper résumé suitable for the business industry. Even though most companies and people appreciate veterans, it was difficult to find a job afterwards, because I had to compete with guys of my age, who used the last ten years to get degrees and working experience.
Many fellow soldiers and brothers of mine also had a very tough time readjusting in modern society. They felt like they lost their purpose, often suffering from post-traumatic stress disorder and depression. In 2016, a documented 20 veterans committed suicide each day.
Only Keener knows the truth about when his connections with Handy Andy ended, and under what circumstances, but basic failures with LLC filings leading to administrative termination of that private business formation do not bode well considering much more stringent public filing requirements for a company like BDPT. He was already late on the first quarterly report under his watch. Now he posts, removes, then reposts a shareholder letter about a reverse split that mentions a shareholder meeting and corporate decisions that needed to be publicly disclosed ahead of time.
Like I said before, BDPT is a gamble and anything can happen on the OTC. But actual facts should be considered and folks should not be attacked for sharing truth.
MC10459
4 주 전
BDPT are either very smart, complete idiots, or a share selling scam. If they have an ace up their sleeve to generate interest, then maybe the RS will work. At this point, I don't believe their very smart. I would be very surprised if their "new product" the weight loss supplement will help, unless it's truly a cut above the hundreds of other weight loss supplements out there. They're not only competing with other weight loss supplements, but they're also competing with the popularity of real weight drugs out there. All their products have, more or less, been copycats of products already on the market. IMO